Press Releases

PUTNAM, CT, USA – (June 18, 2013) – Foster Corporation, a leader in custom polymers for medical devices, introduces ProPell™ thermoplastic polyurethane (TPU) and polyether block amide (PEBA) compounds for improved manufacturing and handling of medical catheters.  These new compounds dramatically reduce tackiness and friction in soft, flexible polymers while maintaining other physical properties of the unmodified polymers. […]

PUTNAM, CT, USA – (May 6, 2013) – Foster Corporation, a leader in custom polymers for medical devices, offers LoPro Clear™, a radiopaque polyurethane that is both x-ray visible and optically transparent.  Catheters extruded from LoPro Clear™, can be located inside the body using fluoroscopy while fluid flow is visually monitored in the portion outside of

PUTNAM, CT, USA – (April 2, 2013) – Foster Corporation, a leader in custom polymer compounds for medical devices, now offers nano-reinforced composites for minimally invasive devices, such as catheters, with reinforcement loadings up to 30% by weight.  Nano-reinforced compounds with high filler loadings provide substantial increase in physical properties of the base resin while maintaining processibility in

PUTNAM, CT, USA – (December 13, 2012) –  Foster Corporation, a leader in custom polymer formulations for medical device and drug delivery applications, now offers regional technical service and product development support in Asia Pacific.  Amar Nilajkar, a ten year veteran of the company, will support medical device and pharmaceutical customers in the region from a

PUTNAM, CT – (November 14, 2012) – Foster Corporation today announced it ranked in Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America.  Foster Corporation grew 149% percent from 2007 to 2011. Foster Corporation’s chief executive officer, Larry Acquarulo credits a growing

Putnam, CT, USA – (October 16, 2012) –  Foster Corporation, a leader in custom medical polymers, reports increased interest in implantable medical device applications by polymer suppliers.  While risk mitigation remains a primary concern, increased acceptance and application of polymers by device manufacturers for temporary and permanent implants presents opportunities for growth for performance polymers. In the 1990’s

Putnam, CT, USA —  (August 6, 2012) — Foster Corporation, a leader in custom medical polymers, has been recognized as one of Connecticut’s 40 fastest growing technology companies in 2012 by the Connecticut Technology Council (CTC) and Marcum LLP. This marks the 9th time in the past 15 years that Foster has been recognized as one

PUTNAM, CT, USA – (June 11, 2012) – Foster Delivery Science, a business unit of Foster Corporation that specializes in contract development and manufacturing of implant and drug delivery polymers, now offers custom radiopaque PEEK compounds for use in long term orthopedic implants. A twin screw extruder within the company’s Class 7 cGMP clean room is

PUTNAM, CT, USA – (May 22, 2012) – Foster Corporation, a leader in custom medical polymers, has added state-of-the-art extrusion compounding capacity for custom pre-colored polymers used in Class I medical applications. The new line is designed to optimize pigment dispersion of challenging colors and polymers, and maximize throughput necessary to reduce compounding costs. Foster’s new

King of Prussia, PA — Arkema Inc. has implemented a 12-month advance notice for product specification changes on all Pebax® SA 01 MED polymers in order to provide medical device manufacturers with the necessary time for regulatory assessment.  Previously, notifications of change for these polymers sold in the medical market were unrestricted, similar to grades sold